Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
18.02.2010 12:00:00

Patterson Companies Reports Improved Third Quarter Operating Results

Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated sales of $820,084,000 for the third quarter of fiscal 2010 ended January 23, an increase of 1% from $811,023,000 in the year-earlier quarter. Net income of $56,049,000 or $.47 per diluted share rose 6% from $52,807,000 or $0.45 per diluted share in the third quarter of fiscal 2009.

Sales of Patterson Dental Supply, Patterson’s largest business, were $572,073,000 in the third quarter, down 2% from $584,140,000 in the year-earlier period.

  • Sales of consumable dental supplies and printed office products rose 2% from last year’s third quarter. Internally-generated sales, excluding foreign currency adjustments and acquisitions, were up slightly, marking the first such sales growth for consumables since the fall of 2008 when the national economy started to deteriorate sharply.
  • Sales of dental equipment and software declined 10% from the year-earlier level, which was consistent with Patterson’s forecast for this period.
  • Sales of other services and products, consisting primarily of technical service parts and labor, software support services and artificial teeth, rose 10% from last year’s third quarter.

Sales of the Webster Veterinary unit increased 5% in the third quarter of fiscal 2010 to $151,771,000. Sales of Patterson Medical, Patterson’s rehabilitation supply and equipment unit, increased 18% to $96,240,000. The acquisitions of Mobilis Healthcare Group in April 2009 and Empi Therapy Solutions in June 2009 accounted for the majority of the third quarter sales increase.

James W. Wiltz, president and chief executive officer, commented: "Patterson’s third quarter operating results were largely consistent with our internal forecasts as our businesses continued to experience the impact of weak economic conditions. We are encouraged that sales of dental consumable supplies started trending upward in the third quarter. However, we believe the purchasing decisions of dental practitioners for new equipment continued to be affected by the soft economy. Sales of dental equipment also faced a difficult comparison with the third quarter of fiscal 2009, when Patterson Dental significantly outperformed the dental equipment market. Although sales of CEREC dental restorative systems were down modestly in the third quarter, sales were up on a sequential quarterly basis. This was encouraging since new systems accounted for a substantial portion of third quarter CEREC sales, not trade-ins for the upgraded imaging unit. We believe the unequalled performance of CEREC has made it the most viable choice for dentists purchasing next-generation CAD/CAM equipment.”

He continued: "Sales of our Webster unit were consistent with forecasted levels in the third quarter, which is the seasonally softest period of the year for our veterinary business. Equipment sales remained sluggish as many veterinary practices continued to be cautious toward purchasing equipment. Patterson Medical’s performance also met our third quarter expectations. We believe this unit continued to gain market share in this period. The assimilation of the Mobilis and Empi acquisitions are proceeding on schedule, and we are pleased with their contributions to our third quarter performance.”

Patterson’s third quarter earnings also benefited from cost control measures that have been instituted in response to the economic downturn. The impact of acquisition-related expenses started diminishing in the third quarter and is expected to continue moderating over the balance of the year.

For full-year fiscal 2010, Patterson is forecasting earnings of $1.74 to $1.78 per diluted share as the company narrowed its previously reported range of $1.70 to $1.80.

As previously announced, Mr. Wiltz will retire as president and chief executive officer of Patterson Companies at the end of the current fiscal year on April 24, 2010. At that time, Scott P. Anderson, currently president of the Patterson Dental Supply subsidiary, will assume those positions.

About Patterson Companies, Inc.

Patterson Companies, Inc. is a value-added distributor serving the dental, companion-pet veterinarian and rehabilitation supply markets.

Dental Market

As Patterson’s largest business, Patterson Dental provides a virtually complete range of consumable dental products, equipment and software, turnkey digital solutions and value-added services to dentists and dental laboratories throughout North America.

Veterinary Market

Webster Veterinary is the nation’s second largest distributor of consumable veterinary supplies, equipment and software, diagnostic products, vaccines and pharmaceuticals to companion-pet veterinary clinics.

Rehabilitation Market

Patterson Medical is the world’s leading distributor of rehabilitation supplies and non-wheelchair assistive patient products to the physical and occupational therapy markets. The unit’s global customer base includes hospitals, long-term care facilities, clinics and dealers.

This release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements are information of a non-historical nature and are subject to risks and uncertainties that are beyond the Company’s ability to control. The Company cautions shareholders and prospective investors that the following factors, among others, may cause actual results to differ materially from those indicated by the forward-looking statements: competition within the dental, veterinary, and rehabilitative and assistive living supply industries; changes in the economics of dentistry, including reduced growth in expenditures by private dental insurance plans, the effects of economic conditions and the effects of healthcare reform, which may affect future per capita expenditures for dental services and the ability and willingness of dentists to invest in high-technology products; the effects of healthcare related legislation and regulation which may affect expenditures or reimbursements for rehabilitative and assistive products; changes in the economics of the veterinary supply market, including reduced growth in per capita expenditures for veterinary services and reduced growth in the number of households owning pets; the ability of the Company to maintain satisfactory relationships with its sales force; unexpected loss of key senior management personnel; unforeseen operating risks; risks associated with the dependence on manufacturers of the Company’s products; and the ability of the Company to successfully integrate the recent acquisitions into its existing business. Forward-looking statements are qualified in their entirety by the cautionary language set forth in the Company's filings with the Securities and Exchange Commission.

Third Quarter Conference Call and Replay

Patterson’s third quarter earnings conference call will start at 10:00 a.m. Eastern today. Investors can listen to a live webcast of the conference call at www.pattersoncompanies.com. Listeners should go to this website at least 15 minutes prior to the call to download and install any necessary audio software. The conference call will be archived on Patterson’s web site. A replay of the third quarter conference call can be heard through February 25, 2010 at 1-303-590-3030 with the 4220042 conference ID.

               
 
PATTERSON COMPANIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except for earnings per share)
(Unaudited)
 
 
Three Months Ended Nine Months Ended
 
January 23, January 24, January 23, January 24,
2010 2009 2010 2009
 
 
Net sales $ 820,084 $ 811,023 $ 2,424,614 $ 2,314,343
 
Gross profit 276,069 269,109 801,290 774,414
 
Operating expenses   182,302     177,567     546,247     520,676  
 
Operating income 93,767 91,542 255,043 253,738
 
Other expense, net   (4,294 )   (6,745 )   (12,412 )   (20,171 )
 
Income before taxes 89,473 84,797 242,631 233,567
 
Income taxes   33,424     31,990     92,182     87,893  
 
Net income $ 56,049   $ 52,807   $ 150,449   $ 145,674  
 
 
Earnings per share:
Basic $ 0.47 $ 0.45 $ 1.27 $ 1.24
Diluted $ 0.47 $ 0.45 $ 1.26 $ 1.23
 
Shares:
Basic 118,518 117,624 118,324 117,645
Diluted 119,434 118,134 119,097 118,391
 
Gross margin 33.7 % 33.2 % 33.0 % 33.5 %
 
Operating expenses as a % of net sales 22.2 % 21.9 % 22.5 % 22.5 %
 
Operating income as a % of net sales 11.4 % 11.3 % 10.5 % 11.0 %
 
Effective tax rate 37.4 % 37.7 % 38.0 % 37.6 %
 
 
PATTERSON COMPANIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in thousands)
       
 
January 23, April 25,
2010 2009
(Unaudited)
ASSETS
Current assets:
Cash and short-term investments $ 267,782 $ 158,065
Receivables, net 471,316 476,156
Inventory 302,637 269,934
Prepaid expenses and other current assets   35,903   33,440
Total current assets 1,077,638 937,595
 
Property and equipment, net 168,657 166,500
Goodwill and other intangible assets 996,345 968,036
Other   80,175   61,489
 
Total Assets $ 2,322,815 $ 2,133,620
 
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable $ 184,035 $ 180,933
Other accrued liabilities 147,117 131,367
Current maturities of long-term debt   -   22,000
Total current liabilities 331,152 334,300
 
Long-term debt 525,000 525,000
Other non-current liabilities   88,311   88,000
Total liabilities 944,463 947,300
 
Stockholders' equity   1,378,352   1,186,320
 
Total Liabilities and Stockholders' Equity $ 2,322,815 $ 2,133,620
               
 
PATTERSON COMPANIES, INC.
SUPPLEMENTARY FINANCIAL DATA
(Dollars in thousands)
(Unaudited)
 
 
 
Three Months Ended Nine Months Ended
January 23, January 24, January 23, January 24,
2010 2009 2010 2009
 
Consolidated Net Sales
Consumable and printed products $ 501,141 $ 476,196 $ 1,586,534 $ 1,468,110
Equipment and software 249,324 271,384 636,979 653,642
Other   69,619     63,443     201,101     192,591  
Total $ 820,084   $ 811,023   $ 2,424,614   $ 2,314,343  
 
Dental Supply
Consumable and printed products $ 293,077 $ 287,709 $ 902,170 $ 909,981
Equipment and software 216,243 239,228 538,989 560,235
Other   62,753     57,203     179,072     170,646  
Total $ 572,073   $ 584,140   $ 1,620,231   $ 1,640,862  
 
Rehabilitation Supply
Consumable and printed products $ 66,739 $ 54,733 $ 229,984 $ 193,925
Equipment and software 24,143 21,942 75,568 71,128
Other   5,358     4,936     17,225     16,293  
Total $ 96,240   $ 81,611   $ 322,777   $ 281,346  
 
Veterinary Supply
Consumable and printed products $ 141,325 $ 133,754 $ 454,380 $ 364,204
Equipment and software 8,938 10,214 22,422 22,279
Other   1,508     1,304     4,804     5,652  
Total $ 151,771   $ 145,272   $ 481,606   $ 392,135  
 
Other (Expense) Income, net
Interest income $ 2,122 $ 1,048 $ 6,491 $ 4,840
Interest expense (6,406 ) (7,000 ) (19,383 ) (23,235 )
Other   (10 )   (793 )   480     (1,776 )
$ (4,294 ) $ (6,745 ) $ (12,412 ) $ (20,171 )
 
 
PATTERSON COMPANIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in thousands)
(Unaudited)
       
Nine Months Ended
January 23, January 24,
2010 2009
 
 
Operating activities:
Net income $ 150,449 $ 145,674
Depreciation & amortization 28,234 21,515
Share-based compensation 6,618 5,800
Change in assets and liabilities, net of acquired   (32,174 )   (100,455 )
Net cash provided by operating activities 153,127 72,534
 
Investing activities:
Additions to property and equipment, net of disposals (17,506 ) (22,838 )
Acquisitions   (28,151 )   (109,942 )
Net cash used in investing activities (45,657 ) (132,780 )
 
Net cash used in financing activities (11,624 ) (56,416 )
Effect of exchange rate changes on cash   13,871     (29,618 )
 
 
Net increase (decrease) in cash and cash equivalents $ 109,717   $ (146,280 )

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 003,65 0,16%
NASDAQ 100 20 776,23 0,17%
S&P 400 MidCap 1 854,40 -0,45%